TECH
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)Bio-Techne Corp - Common Stock (TECH) [ST]
www.bio-techne.com ↗▲ 1.70%
prev close
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Congressional Trades
3
All tracked trades
Members Trading
2
Unique members
Net Activity
+1
2 buys · 1 sells
Members Who Traded This Stock
3 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2025-04-29 | TECHBio-Techne Corp - Common Stock | Buy | $1,001 - $15,000 | 335d ago | — | |
| 2025-04-08 | TECHBio-Techne Corp - Common Stock | Sell | $1,001 - $15,000 | 329d ago | — | |
| 2025-02-25 | TECHBio-Techne Corp - Common Stock | Buy | $1,001 - $15,000 | 371d ago | — |
2025-04-29
April McClain Delaney
TECH
Amount
$1,001 - $15,000
Filed
335d ago
2025-04-08
Rob Bresnahan
TECH
Amount
$1,001 - $15,000
Filed
329d ago
2025-02-25
Rob Bresnahan
TECH
Amount
$1,001 - $15,000
Filed
371d ago
Recent News
Powered by Polygon.io
ELISpot & FluoroSpot Assay Market Report 2026-2031: Mabtech, Oxford Immunotec Global, and Cellular Technology Dominate the Landscape
Bio-Techne Declares Dividend
Middle East Exosomes Market Research Report 2025-2033: Diagnostic and Therapeutic Adoption, R&D Investment, and Liquid Biopsy Demand Drive Growth
BIO-TECHNE DECLARES DIVIDEND
Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
Trade Timeline
Congressional activity, newest first
April McClain Delaney
2025-04-29 · Purchase
$1,001 - $15,000
Rob Bresnahan
2025-04-08 · Sale
$1,001 - $15,000
Rob Bresnahan
2025-02-25 · Purchase
$1,001 - $15,000